FP7H2020HORIZON
Stichting het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis
- Country
- NLNetherlands
- Defence projects
- 0
- Projects, all programmes
- 139
- As coordinator
- 49
- EU contribution (CORDIS)
- EUR 110,618,594
- Active
- 2008 to 2026
Projects
139 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CARE1First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma | HORIZON | 2023 | Participant | EUR 280,650 |
| Fragment-ScreenFrom fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence | HORIZON | 2023 | Participant | EUR 269,645 |
| STREXIT2A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA | HORIZON | 2023 | Participant | EUR 95,000 |
| PRIME-ROSEPRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials | HORIZON | 2023 | Participant | EUR 267,300 |
| STEPUPIORSTWINNING FOR A EUROPEAN CONSORTIUM OF RECTAL CANCER RESEARCH INSTITUTIONS THROUGH STEPPING UP SCIENTIFIC, TECHNOLOGICAL AND INNOVATION EXCELLENCE OF IORS | HORIZON | 2022 | Participant | EUR 250,000 |
| OncoFetal_PloidyUnderstanding aneuploidy tolerance in cancer by studying early embryogenesis | HORIZON | 2022 | Coordinator | EUR 190,374 |
| RE_LOCATELocation, location, location: the (re-)positioning of regulatory elements in the mammalian genome. | HORIZON | 2022 | Coordinator | EUR 2,493,875 |
| ReverTReversing T cell dysfunction in cancer by multimodal genetic screening | HORIZON | 2022 | Coordinator | EUR 2,499,375 |
| STRONG-AYATHE STRONG-AYA INITIATIVE: IMPROVING THE FUTURE OF YOUNG ADULTS WITH CANCER | HORIZON | 2022 | Coordinator | EUR 1,437,238 |
| BreaKerDissecting how breast cancer-associated inflammation shapes invariant natural killer T cell activity during metastatic progression | H2020 | 2022 | Coordinator | EUR 175,572 |
| ONCOVALUEImplementing value-based oncology care at European cancer hospitals: An AI-based framework for assessing real-life effectiveness of novel cancer therapies in real-time | HORIZON | 2022 | Participant | EUR 1,010,750 |
| 4.UNCAN.euA Coordination and Support Action to prepare UNCAN.eu platform | HORIZON | 2022 | Participant | EUR 79,872 |
| ISIDOReIntegrated Services for Infectious Disease Outbreak Research | HORIZON | 2022 | Participant | EUR 62,000 |
| GlioSurgRole of astrogliosis in the recurrence of brain tumors after microsurgical resection | HORIZON | 2022 | Associated partner | EUR 0 |
| BIGPICTURECentral Repository for Digital Pathology | H2020 | 2021 | Participant | EUR 200,000 |
| I.am.a.LADFrom chromatin fibers to lamina-associated domains: what are the recognition determinants? | H2020 | 2021 | Coordinator | EUR 175,572 |
| PERSIST-SEQBuilding a reproducible single-cell experimental workflow to capture tumour cell persistence | H2020 | 2021 | Third party | Not stated |
| CCE_DARTBuilding Data Rich Clinical Trials | H2020 | 2021 | Participant | EUR 343,831 |
| TorsionAtLaminaTWISTING THE BOUNDARIES: ROLE OF TOPOISOMERASE 1 AT THE NUCLEAR LAMINA | H2020 | 2020 | Coordinator | EUR 175,572 |
| CAPABLECAncer PAtients Better Life Experience | H2020 | 2020 | Participant | EUR 356,795 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.